3 Health Services Stocks Moving The Industry Upward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 51 points (-0.3%) at 18,140 as of Monday, May 11, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,286 issues advancing vs. 1,726 declining with 119 unchanged.

The Health Services industry currently sits up 0.4% versus the S&P 500, which is down 0.2%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Edwards Lifesciences ( EW) is one of the companies pushing the Health Services industry higher today. As of noon trading, Edwards Lifesciences is up $1.00 (0.8%) to $127.40 on average volume. Thus far, 558,015 shares of Edwards Lifesciences exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $126.00-$128.43 after having opened the day at $126.15 as compared to the previous trading day's close of $126.40.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences has a market cap of $13.3 billion and is part of the health care sector. Shares are down 2.7% year-to-date as of the close of trading on Friday. Currently there are 9 analysts who rate Edwards Lifesciences a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Edwards Lifesciences as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and compelling growth in net income. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Edwards Lifesciences Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, HCA Holdings ( HCA) is up $0.54 (0.7%) to $77.44 on average volume. Thus far, 1.4 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $76.68-$77.49 after having opened the day at $76.82 as compared to the previous trading day's close of $76.90.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $31.7 billion and is part of the health care sector. Shares are up 4.8% year-to-date as of the close of trading on Friday. Currently there are 16 analysts who rate HCA Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates HCA Holdings as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full HCA Holdings Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, Anthem ( ANTM) is up $1.05 (0.7%) to $159.45 on average volume. Thus far, 750,445 shares of Anthem exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $158.08-$160.53 after having opened the day at $158.24 as compared to the previous trading day's close of $158.40.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial and Specialty Business, Government Business, and Other. Anthem has a market cap of $41.2 billion and is part of the health care sector. Shares are up 24.0% year-to-date as of the close of trading on Friday. Currently there are 8 analysts who rate Anthem a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Anthem as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Anthem Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

More from Markets

3 Things Investors Must Know for Monday

3 Things Investors Must Know for Monday

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric